Location History:
- St. Joseph, MO (US) (2016 - 2019)
- Savannah, MO (US) (2020 - 2023)
Company Filing History:
2 out of 306 
2 out of 832,891 Years Active: 2016-2020
Title: Axel Neubauer: Innovator in Immunogenic Compositions
Introduction
Axel Neubauer is a notable inventor based in St. Joseph, MO (US). He has made significant contributions to the field of immunology, particularly in the development of immunogenic compositions aimed at combating mycoplasma infections. With a total of 4 patents to his name, Neubauer's work is paving the way for advancements in vaccine development.
Latest Patents
Neubauer's latest patents include an immunogenic composition comprising mycoplasma antigens. This invention relates to a composition that includes one or more antigens of mycoplasma bacteria and a pharmaceutically acceptable carrier. Additionally, he has developed a method for making a mycoplasma vaccine, which involves cultivating mycoplasma bacteria in a serum-reduced or swine serum-free eukaryotic cell system. This method aims to prepare an immunogenic composition for the treatment and prophylaxis of mycoplasma infections.
Career Highlights
Throughout his career, Axel Neubauer has worked with reputable organizations, including Boehringer Ingelheim Vetmedica GmbH. His expertise in immunology and vaccine development has positioned him as a key figure in the industry.
Collaborations
Neubauer has collaborated with several professionals in his field, including Dianna M Murphy Jordan and Brian Thomas Martinson. These collaborations have likely contributed to the success of his innovative projects.
Conclusion
Axel Neubauer's contributions to immunogenic compositions and vaccine development highlight his role as an influential inventor in the field of immunology. His work continues to impact the fight against mycoplasma infections, showcasing the importance of innovation in healthcare.